Frontiers in Medicine (May 2018)

Phage Therapy: Beyond Antibacterial Action

  • Andrzej Górski,
  • Andrzej Górski,
  • Andrzej Górski,
  • Ewa Jończyk-Matysiak,
  • Ryszard Międzybrodzki,
  • Ryszard Międzybrodzki,
  • Ryszard Międzybrodzki,
  • Beata Weber-Dąbrowska,
  • Beata Weber-Dąbrowska,
  • Marzanna Łusiak-Szelachowska,
  • Natalia Bagińska,
  • Jan Borysowski,
  • Małgorzata B. Łobocka,
  • Małgorzata B. Łobocka,
  • Alicja Węgrzyn,
  • Grzegorz Węgrzyn

DOI
https://doi.org/10.3389/fmed.2018.00146
Journal volume & issue
Vol. 5

Abstract

Read online

Until recently, phages were considered as mere “bacteria eaters” with potential for use in combating antimicrobial resistance. The real value of phage therapy assessed according to the standards of evidence-based medicine awaits confirmation by clinical trials. However, the progress in research on phage biology has shed more light on the significance of phages. Accumulating data indicate that phages may also interact with eukaryotic cells. How such interactions could be translated into advances in medicine (especially novel means of therapy) is discussed herein.

Keywords